We are live on
!
Find out more
CCM
Coliseum Capital Management Portfolio holdings
AUM
$1.22B
1-Year Est. Return
18.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.89%
1 Year Est. Return
+18.72%
3 Year Est. Return
+13.66%
5 Year Est. Return
+18.68%
10 Year Est. Return
+493.05%
AUM
$1.13B
AUM Growth
-$1.2M
(-0.11%)
Cap. Flow
-$28.4M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GMS
GMS Inc
GMS
|
+$15.7M |
| 2 |
Builders FirstSource
BLDR
|
+$2.06M |
| 3 |
PGTI
PGT, Inc.
PGTI
|
+$400K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MODV
ModivCare
MODV
|
+$46.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 62.31% |
| 2 | Healthcare | 20.67% |
| 3 | Consumer Discretionary | 16.9% |
| 4 | Communication Services | 0.12% |
Similar funds
GC
AG
DGM
DPI
SC
KB
NPIC
IB
Coliseum Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Coliseum Capital Management held 9 positions worth $1.13B, down 0.11% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Coliseum Capital Management's Q3 2021 filing shows 1 new, 2 increased, 1 reduced and 1 closed positions. Its largest new stake was PGT, Inc.: 18,732 shares worth $358K. The largest sale was ModivCare, an estimated $46.3M.
By sector, the portfolio is most concentrated in Industrials at 62% of assets, up from 56% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Coliseum Capital Management's largest Q3 2021 buy was PGT, Inc.: 18,732 shares worth $358K.
- Coliseum Capital Management added most to GMS Inc in Q3 2021, an estimated $15.7M increase.
- Coliseum Capital Management's biggest Q3 2021 reduction was ModivCare, cutting an estimated $46.3M.
- Coliseum Capital Management's ten largest holdings make up 100% of its $1.13B portfolio in Q3 2021.
- Coliseum Capital Management opened 1 new position and closed 1 in Q3 2021.
- Coliseum Capital Management's portfolio value fell 0.11% quarter-over-quarter to $1.13B.
Based on Coliseum Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.